one more question - the Car-t data readout - what is it? I thought they had just tested the safety on a very tiny number of people ... or are they farther along than that?
CEO Amit Kumar and Director Arnold Baskies continue to invest capital in Anixa.....
During his investor presentation, Dr. Kumar will discuss Anixa's portfolio of first-in-class oncology/immunology assets under development, with vaccines to prevent cancer and a CAR-T cell therapy to treat cancer. The Company's robust pipeline over the next 12 months includes three candidates based on two modalities, three indications, and two ongoing clinical trials.
News 
Market Data 
Discover 
